Discovery of P-450

A major class of oxidative transformations was initially characterized in 1955 by O. Hayaishi in Japan and H.S. Mason in the United States. Since one class of oxygenases had requirements for both an oxidant (molecular oxygen) and a reductant (reduced NAPD), it was given the trivial name “mixed-function oxidases.”

Ryo Sato
Ryo Sato

An understanding of the biochemical nature of these reactions grew from early studies by Garfinkel and Klingenberg, who observed a carbon monoxide-binding pigment with unique absorption at 450 mµ in liver microsomes. Based on the unusual spectrum, he concluded that it was probably not an iron hemoprotein. Klingenberg found the CO-binding pigment in rat liver microsomes, again reporting the unique aspects of difference spectrum. The pigment was ultimately characterized as a cytochrome in 1962 by Omura and Sato, using rabbit liver microsomes. Through the use of detergent solubilization, they showed that the resultant “P-420” was a cytochrome with typical a, b, and Soret absorption bands.

Tsuneo Omura
Tsuneo Omura

The role of this unique cytochrome in drug metabolism was then uncovered in studies using adrenal microsomes for the catalysis of the hydroxylation of 17-hydroxy progesterone to corexolone. Having prepared detergent solubilized adrenal microsomes, Cooper and co-workers found that they contained a CO-binding pigment similar to that of pig liver, as reported by Klingenberg. Relying on the studies of Ryan and Engel that had shown that the adrenal C-21 hydroxylation reaction was inhibited by CO, and the inhibition could be reversed by white light, Estabrook, Cooper, and Rosenthal performed classic photoactivation experiments and proved that this cytochrome was the oxygen-combining component in the C-21 hydroxylation of steroids.

In the 35 years since its identification as the terminal component of oxygenation reactions, cytochrome P-450 has grown beyond drug metabolism to influence many other sciences. The first crystallization of a mammalian P-450 was reported in 1999 by Eric Johnson and co-workers.


Index | Intro | The Beginning | Oxidation
Sulfation | Glucuronides | Acetylation, Methylation
Reduction | Mercapturic Acid | Founding of the Field
Drug Metabolism Methodology | In Vitro Technology | P-450
The Future

BAS Home